Literature DB >> 9543368

In situ hybridization of hepatitis B DNA in hepatitis B-associated glomerulonephritis.

X Y He1, L J Fang, Y E Zhang, F Y Sheng, X R Zhang, M Y Guo.   

Abstract

Renal tissues from 43 of 49 children with hepatitis B virus-associated glomerulonephritis (HBV-GN) were examined for HBV DNA by in situ hybridization (ISH) assay within the last 10 years. HBV DNA was identified in 41 of the 43 cases (95.3%). HBV DNA was distributed generally in the nucleus and cytoplasm of epithelial cells and mesangial cells of glomeruli, and epithelial cells of renal tubules. HBV DNA also existed simultaneously in renal interstitial tissues in some of these cases. The positive results from HBV DNA ISH correlated well with HBV antigen assays. The analyses implied that the more extensive the existence of HBV DNA in the nephron unit and interstitial tissue, the more severe the clinical manifestation. The duration of proteinuria in cases with HBV DNA in renal tubules was much longer than in those with no HBV DNA in renal tubules. The persistence of the HBV genome or genes in the kidney could lead to the expression of viral antigens in renal tissues and might cause cellular pathological alteration. This would support utilization of antiviral therapy, such as cytokines, in the treatment of HBV-GN.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9543368     DOI: 10.1007/s004670050417

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  13 in total

Review 1.  Extrahepatic manifestations of chronic viral hepatitis.

Authors:  N T Pyrsopoulos; K R Reddy
Journal:  Curr Gastroenterol Rep       Date:  2001-02

2.  Study on hepatitis B virus pre-S/S gene mutations of renal tissues in children with hepatitis B virus-associated membranous nephropathy.

Authors:  Se Eun Kim; Yeong Hong Park; Woo Yeong Chung
Journal:  Pediatr Nephrol       Date:  2006-06-22       Impact factor: 3.714

3.  Existence and significance of hepatitis B virus DNA in kidneys of IgA nephropathy.

Authors:  Nian-Song Wang; Zhao-Long Wu; Yue-E Zhang; Lu-Tan Liao
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

4.  Chronic hepatitis B serum promotes apoptotic damage in human renal tubular cells.

Authors:  Cun-Liang Deng; Xin-Wen Song; Hai-Jun Liang; Chen Feng; Yun-Jian Sheng; Ming-Yong Wang
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

5.  Role of hepatitis B virus infection in pathogenesis of IgA nephropathy.

Authors:  Nian-Song Wang; Zhao-Long Wu; Yue-E Zhang; Mu-Yi Guo; Lv-Tan Liao
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

6.  S gene mutations of HBV in children with HBV-associated glomerulonephritis.

Authors:  Hongzhu Lu; Hui Zhu; Jianhua Zhou
Journal:  Virol J       Date:  2012-03-05       Impact factor: 4.099

7.  Hepatitis B virus X protein modulates apoptosis in human renal proximal tubular epithelial cells by activating the JAK2/STAT3 signaling pathway.

Authors:  Ping He; Dan Zhang; Hong Li; Xu Yang; Detian Li; Yongzhen Zhai; Li Ma; Guohe Feng
Journal:  Int J Mol Med       Date:  2013-03-07       Impact factor: 4.101

8.  AIM2 mediates inflammation-associated renal damage in hepatitis B virus-associated glomerulonephritis by regulating caspase-1, IL-1β, and IL-18.

Authors:  Junhui Zhen; Le Zhang; Jiachao Pan; Shumin Ma; Xiaojian Yu; Xiaobo Li; Shijun Chen; Wenjun Du
Journal:  Mediators Inflamm       Date:  2014-02-20       Impact factor: 4.711

9.  Purified hepatitis B virus induces human mesangial cell proliferation and extracellular matrix expression in vitro.

Authors:  Zongli Diao; Jiaxiang Ding; Chenghong Yin; Liyan Wang; Wenhu Liu
Journal:  Virol J       Date:  2013-10-04       Impact factor: 4.099

10.  Expression of AIM2 is high and correlated with inflammation in hepatitis B virus associated glomerulonephritis.

Authors:  Wenjun Du; Junhui Zhen; Zhaomin Zheng; Shumin Ma; Shijun Chen
Journal:  J Inflamm (Lond)       Date:  2013-12-10       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.